Navigation Links
Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
Date:7/28/2009

nt months include the appointments of Jarrod Pontius as Vice President, Chief Legal Officer and Secretary and the appointment of Keith Cheesman as Senior Vice President and Chief Financial Officer.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kendle Names Jarrod Pontius Chief Legal Officer
2. Kendle Expands Asia/Pacific Operations with Opening of Offices in Kuala Lumpur, Bangkok and Manila
3. Kendle Announces First Quarter 2009 Results
4. Kendle Announces Departure of Senior Vice President and CFO Karl Buzz Brenkert III; Appoints Keith A. Cheesman as Successor
5. Kendle to Host Conference Call to Discuss Revised 2009 Outlook
6. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
7. Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences
8. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call
9. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
10. Kendle to Present at the 2008 Credit Suisse Health Care Conference
11. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... N.J. , March 3, 2015  Thingee Corporation, ... will be delivering a presentation entitled, "Technology Adoption: Making ... Thriving through Innovations and Technology ,  in ... March 11 to 13, 2015. Audiences looking to learn ... effectively will want to be in the audience for ...
(Date:3/3/2015)... March 03, 2015 Genedata, a ... discovery and life science research, today announced that ... enterprise platform for use at Pfizer biopharma research ... Genedata is supporting Pfizer’s global deployment and roll ... Centers for Therapeutic Innovation (CTI), and Pharmaceutical Sciences ...
(Date:3/3/2015)... , March 3, 2015  Johnson & Johnson ... South San Francisco (JLABS @SSF), a ... South San Francisco, Calif. The ... up to 50 startups from across the healthcare spectrum ... The first resident startups have been ...
(Date:3/3/2015)... , March 3, 2015  PDL BioPharma, Inc. ... today announced that the third of three shareholder lawsuits ... without prejudice. On February 2, 2015, a ... September on behalf of a putative class of purchasers ... et al., No. 2:14-CV-01526-APG-NJK (D. Nev.), was voluntarily dismissed ...
Breaking Biology Technology:Thingee to present at 11th Annual Synergistix Users Conference 2Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2
... a way to wake up the immune system to ... a nanoscale container called a vault directly into lung ... disease growth. The vaults, barrel-shaped nanoscale capsules found ... to slowly release a protein, the chemokine CCL21, into ...
... physical therapists are delighted the members of the California ... importance of Senate Bill 924 and its value to ... Physical Therapy Association, will improve the health care process ... delays and unnecessary costs because they have been unable ...
... Calif., May 3, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... and CEO, will provide an update on the progress of ... company,s business strategy at two investor conferences in the month ... Lynch Health Care Conference at 10:40 am PT (1:40 pm ...
Cached Biology Technology:UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs 2UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs 3UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs 4Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences 2
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... Boston, MA Tuesday, March 3, 2015 at 11.20 ... Orlando, FL Wednesday, March 4, 2015 ... To access the live webcasts for these events, please visit ...
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... dangers to human health and the environment. North Carolina ... from the U.S. Environmental Protection Agency (EPA) that targets ... overflows every year, and will give urban planners new ... At issue are overflows from "sanitary" sewer systems, ...
... scientists have inventoried an astonishing abundance, diversity and distribution of ... that somehow manage a living in a frigid black world ... Revealed via deep-towed cameras, sonar and other vanguard ... now number 17,650, a diverse collection of species ranging from ...
... b3c newswire / - KINAXO Biotechnologies GmbH ... two new investors in the company, Leifina and Conmit ... Schumacher has been elected as a new member of ... Ullrich, Hellmut Kirchner, Manfred Ferber as well as the ...
Cached Biology News:Lose the fat: Targeting grease to curtail sewer overflows 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Rb anti-Occludin (C-term GST)...
anti-JNK2 Immunogen: Recombinant human JNK2 protein Accession Number: NM_002752 Quality Assurance: Routinely evaluated by immunoblot. Molecular Weight: 46 and/or 54 kDa Available ...
...
Biology Products: